BioCentury | Nov 2, 2009
Company News

PPD dermatology, metabolic, genitourinary news

...registration. The newco also will have PPD's dermatology program gained from the April acquisition of Magen BioSciences Inc....
BioCentury | Apr 13, 2009
Company News

Charles River Laboratories Inc., Magen, PPD Inc. deal

...company Magen BioSciences for $14.5 million in cash. PPD gains Magen's undisclosed preclinical dermatology compounds. Magen...
...compound partnering program (see BioCentury, Jan. 14, 2008). Charles River Laboratories Inc. (NYSE:CRL), Wilmington, Mass. Magen BioSciences Inc....
BioCentury | Mar 24, 2008
Finance

Ebb & Flow

...Strategies, Knightsbridge Advisers, TrueBridge Capital Partners and VenCap International. The fund's investments include dermatology company Magen...
BioCentury | Jan 14, 2008
Company News

Magen, Eli Lilly deal

...Eli Lilly granted Magen exclusive, worldwide rights to develop and commercialize a series of undisclosed preclinical...
...commercialize a series of undisclosed preclinical compounds for dermatology applications. Further terms were not disclosed. Magen BioSciences Inc....
BioCentury | Dec 10, 2007
Company News

Magen scientific advisory board update

...in skin at Massachusetts General Hospital and Brigham and Women's Hospital at Harvard Medical School Magen...
BioCentury | Apr 16, 2007
Company News

Transport Pharmaceuticals board of directors update

...Inc. , Framingham, Mass. Business: Drug delivery, Dermatology Appointed: Brain Gallagher, president and CEO of Magen Biosciences Inc. WIR...
BioCentury | Sep 18, 2006
Finance

Ebb & Flow

...and neurological illnesses. IDG recently invested in the $15.4 million series A round raised by Magen...
BioCentury | Sep 4, 2006
Company News

Magen board of directors update

Magen BioSciences Inc. , Cambridge, Mass. Business: Dermatology Appointed: Robert Higgins, a managing general partner at Highland Capital Partners WIR Staff...
BioCentury | Aug 29, 2006
Financial News

Magen raises $15.4 million

...Dermatology company Magen ( Cambridge , Mass.) raised $15.4 million in a series A round led...
...existing investors Alexandria Real Estate; Arch Venture Partners; Lux Capital; TVM Capital; and Venrock Associates. Magen...
...to treat or prevent diseases caused by exposure to UV light. Highland's Robert Higgins joined Magen's...
BioCentury | Jul 24, 2006
Company News

Magen management update

Magen BioSciences Inc. , Cambridge, Mass. Business: Dermatology Hired: Brian Gallagher as president and CEO, formerly chairman and CEO of CollaGenex Pharmaceuticals Inc. WIR Staff Dermatology...
Items per page:
1 - 10 of 12
BioCentury | Nov 2, 2009
Company News

PPD dermatology, metabolic, genitourinary news

...registration. The newco also will have PPD's dermatology program gained from the April acquisition of Magen BioSciences Inc....
BioCentury | Apr 13, 2009
Company News

Charles River Laboratories Inc., Magen, PPD Inc. deal

...company Magen BioSciences for $14.5 million in cash. PPD gains Magen's undisclosed preclinical dermatology compounds. Magen...
...compound partnering program (see BioCentury, Jan. 14, 2008). Charles River Laboratories Inc. (NYSE:CRL), Wilmington, Mass. Magen BioSciences Inc....
BioCentury | Mar 24, 2008
Finance

Ebb & Flow

...Strategies, Knightsbridge Advisers, TrueBridge Capital Partners and VenCap International. The fund's investments include dermatology company Magen...
BioCentury | Jan 14, 2008
Company News

Magen, Eli Lilly deal

...Eli Lilly granted Magen exclusive, worldwide rights to develop and commercialize a series of undisclosed preclinical...
...commercialize a series of undisclosed preclinical compounds for dermatology applications. Further terms were not disclosed. Magen BioSciences Inc....
BioCentury | Dec 10, 2007
Company News

Magen scientific advisory board update

...in skin at Massachusetts General Hospital and Brigham and Women's Hospital at Harvard Medical School Magen...
BioCentury | Apr 16, 2007
Company News

Transport Pharmaceuticals board of directors update

...Inc. , Framingham, Mass. Business: Drug delivery, Dermatology Appointed: Brain Gallagher, president and CEO of Magen Biosciences Inc. WIR...
BioCentury | Sep 18, 2006
Finance

Ebb & Flow

...and neurological illnesses. IDG recently invested in the $15.4 million series A round raised by Magen...
BioCentury | Sep 4, 2006
Company News

Magen board of directors update

Magen BioSciences Inc. , Cambridge, Mass. Business: Dermatology Appointed: Robert Higgins, a managing general partner at Highland Capital Partners WIR Staff...
BioCentury | Aug 29, 2006
Financial News

Magen raises $15.4 million

...Dermatology company Magen ( Cambridge , Mass.) raised $15.4 million in a series A round led...
...existing investors Alexandria Real Estate; Arch Venture Partners; Lux Capital; TVM Capital; and Venrock Associates. Magen...
...to treat or prevent diseases caused by exposure to UV light. Highland's Robert Higgins joined Magen's...
BioCentury | Jul 24, 2006
Company News

Magen management update

Magen BioSciences Inc. , Cambridge, Mass. Business: Dermatology Hired: Brian Gallagher as president and CEO, formerly chairman and CEO of CollaGenex Pharmaceuticals Inc. WIR Staff Dermatology...
Items per page:
1 - 10 of 12